EWTX•benzinga•
Edgewise Therapeutics Priced An Underwritten Offering Of 9.94M Shares At $20.13 Per Share. Edgewise Anticipates Gross Proceeds From The Offering To Be Approximately $200M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 2, 2025 by benzinga